Less Ads, More Data, More Tools Register for FREE

Pin to quick picksACRL.L Regulatory News (ACRL)

  • There is currently no data for ACRL

Placing Shares Admitted

11 Dec 2017 08:01

RNS Number : 8758Y
Accrol Group Holdings PLC
11 December 2017
 

11 December 2017

 

The information contained within this announcement is deemed by the Company to constitute inside information stipulated under the Market Abuse Regulation (EU) No. 596/2014. Upon the publication of this announcement via the Regulatory Information Service, this inside information is now considered to be in the public domain.

 

Accrol Group Holdings plc

(AIM: ACRL)

 

Placing Shares Admitted, Appointment of Director

And Total Voting Rights

 

Accrol Group Holdings plc (the "Company" or "Accrol"), the AIM-listed leading independent tissue converter, notes that the 36,000,000 new ordinary shares issued pursuant to the recently announced Placing to raise ÂŁ18 million have been admitted to trading earlier today ("Admission"). As a consequence, the Revised Banking Facilities and the appointment of Dan Wright as a Director of the Company (each as described in the Company's announcement of 20 November 2017 titled "Proposed Placing of ÂŁ18m and Lifting of Suspension") are now effective.

 

Peter Cheung, Chairman of Accrol, said: "I would like to take this opportunity to thank all our shareholders, once again, for their support and understanding over the past two months.

 

 "On behalf of all the directors, I am delighted to welcome Dan to the Board. Dan is an experienced operator with considerable knowledge of our business and a strong understanding of the mechanics of the industry and we look forward to working with him."

 

Dan Wright

 

The following information on Dan Wright is required to be disclosed under Schedule Two, paragraph (g) (i)-(viii) of the AIM Rules for Companies:

 

Daniel ("Dan") Patrick Wright, aged 45, is currently a director of the following companies:

 

· NorthEdge Capital I GP LLP

· Waterloo Street BPRA Property Fund LLP

· Vision Support Services Group Limited

· Impulse Partners Limited

· Gomrath Limited

 

In addition, Dan has held the following directorships in the past five years:

 

· Highflex Holdings (UK) Limited (in administration effective 2 August 2017)

· NorthEdge Capital Fund I GP Limited

· NorthEdge Capital Corporate Limited

· NorthEdge Capital Nominee Limited

· NorthEdge Capital Founder GP Limited

· Accrol Group Holdings plc

· Accrol UK Limited

· MP Topco Limited

· Bretherton Barns Limited

· NorthEdge Capital LLP

· Piccadilly Assured Homes Limited

· P. & M.J. Wright (Holdings) Limited

 

Dan is interested in 200,000 Accrol Shares representing 0.16% of the entire issued share capital of Accrol Group Holdings plc.

 

There is no further information on Dan required to be disclosed under Schedule Two, paragraph (g) (i)-(viii) of the AIM Rules for Companies.

 

Total Voting Rights

 

Following Admission, there are [129,012,002] ordinary shares of ÂŁ0.01 in the capital of Accrol in issue, with one voting right each. The Company does not hold any shares in treasury. The number of Ordinary Shares with voting rights is therefore [129,012,002]. Accordingly, this number should be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure and Transparency Rules.

 

 

Enquiries:

 

Accrol Group Holdings plc Tel: +44 (0) 1254 278 844

Gareth Jenkins, CEO

James Flude, Finance Director

 

Zeus Capital Limited (Nominated Adviser & Broker)

Dan Bate / Andrew Jones Tel: +44 (0) 161 831 1512

Dominic King / John Goold Tel: +44 (0) 203 829 5000

 

Belvedere Communications Limited Tel: +44 (0) 203 567 0510

Cat Valentine (cvalentine@belvederepr.com) Mob: +44 (0) 7715 769 078

Kim van Beeck (kvbeeck@belvederepr.com) Mob: +44 (0) 7477 967 446

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
POSUWONRBRAURAA
Date   Source Headline
27th Mar 20247:26 amGNWForm 8.5 (EPT/RI) - Accrol Group Holdings Plc
26th Mar 20243:33 pmRNSTR-1
26th Mar 20241:57 pmPRNForm 8.3 - Accrol Group Holdings plc
26th Mar 20241:01 pmRNSForm 8.3 - Accrol Group Holdings Plc
26th Mar 202412:57 pmRNSForm 8.3 - Accrol Group Holdings PLC
26th Mar 202412:00 pmRNSForm 8.3 - Accrol Group Holdings plc
26th Mar 202411:51 amPRNForm 8.3 - Accrol Group Holdings PLC
26th Mar 202410:02 amPRNForm 8.3 - Accrol Group Holdings plc
26th Mar 20249:17 amGNWForm 8.5 (EPT/RI) - Accrol Group Holdings Plc
25th Mar 20245:09 pmPRNForm 8.3 - Accrol Group Holdings PLC
25th Mar 20245:03 pmPRNForm 8.3 - Accrol Group Holdings Plc
25th Mar 20243:08 pmRNSForm 8.3 - ACCROL GROUP HOLDINGS PLC
25th Mar 20242:31 pmRNSForm 8.3 - Accrol Group Holdings
25th Mar 20242:19 pmRNSForm 8.3 - Accrol Group Holdings Plc
25th Mar 20241:33 pmPRNForm 8.3 - Accrol Group Holdings plc
25th Mar 202411:52 amRNSForm 8.3 - Accrol Group Holdings PLC
25th Mar 202411:00 amPRNForm 8.3 - Accrol Group Holdings plc
25th Mar 202410:51 amRNSForm 8 (DD) - Accrol Group Holdings PLC
25th Mar 202410:24 amRNSForm 8.3 - Accrol Group Holdings PLC
25th Mar 20247:59 amGNWForm 8.5 (EPT/RI) - Accrol Group Holdings Plc
22nd Mar 20241:24 pmPRNForm 8.3 - Accrol Group Holdings plc
22nd Mar 202412:28 pmRNSForm 8.3 -Accrol Group Holdings PLC
22nd Mar 20248:17 amRNSForm 8.3 - Accrol Group Holdings plc
22nd Mar 20247:00 amRNSRecommended Cash Offer
1st Mar 20243:52 pmRNSTR-1
8th Feb 20247:00 amRNSDirector/PDMR Shareholding
1st Feb 20247:00 amRNSTR-1
30th Jan 20247:00 amRNSHalf Year Results
26th Jan 20247:00 amRNSNotice of Results and Investor Webinar
19th Jan 20247:00 amRNSTR-1
18th Jan 20247:00 amRNSAcquisition of Severn Delta Limited
22nd Nov 20237:00 amRNSHalf Year Trading Update
24th Oct 20232:37 pmRNSResult of AGM
18th Oct 202311:52 amRNSTR-1
18th Oct 202311:49 amRNSTR-1
17th Oct 20235:40 pmRNSTR-1
28th Sep 20239:47 amRNSNotice of AGM and Posting of Annual Report 2023
26th Sep 20237:00 amRNSFinal Results 2023
22nd Sep 20237:00 amRNSNotice of Results and Online Presentations
30th Aug 20231:20 pmRNSTR-1
22nd Aug 20237:00 amRNSDirector Dealings
18th Jul 20234:02 pmRNSTR-1
9th Jun 202311:43 amRNSTR-1
16th May 20237:00 amRNSTrading Update
2nd May 20237:00 amRNSBoard Changes
18th Apr 20234:40 pmRNSTR-1
27th Mar 20233:22 pmRNSTR-1
24th Mar 20231:38 pmRNSTR-1
7th Mar 20237:00 amRNSAppointment of Joint Broker
1st Mar 20237:00 amRNSLicensing Agreement with Unilever

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.